You are about to leave the website of Otsuka Novel Products GmbH and view the content of an external website. Otsuka Novel Products GmbH cannot be held responsible for the content of external websites.
Otsuka searches for innovative solutions to address gaps in TB treatment.
Otsuka’s working on widening access to a multidrug-resistant TB (MDR-TB) medicine while ensuring antimicrobial stewardship.
Partnerships and collaborations are essential in the fight against TB.
Otsuka’s actively working to simplify MDR-TB treatment to respond to urgent patient needs.